Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abbott Laboratories

123.67
+3.162.62%
Post-market: 123.800.1300+0.11%19:59 EDT
Volume:19.57M
Turnover:2.43B
Market Cap:215.17B
PE:16.06
High:125.63
Open:122.63
Low:122.27
Close:120.51
Loading ...

BUZZ-Abbott rises after continuous glucose monitor reduce hospitalizations

Reuters
·
15 May

Abbott's FreeStyle Libre Technology Significantly Reduces Cardiovascular Hospitalizations in Diabetes Patients, New Study Reveals

Reuters
·
15 May

Abbott's Libre® Technology Is First Continuous Glucose Monitor Associated With Reduced Hospitalizations for Heart Complications in People With Diabetes

THOMSON REUTERS
·
15 May

DIARY-India economic, corporate events on May 15

Reuters
·
15 May

Abbott Laboratories Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
14 May

Neogen Corporation Announces Board Transition: Andrea Wainer Joins as James P. Tobin Retires

Reuters
·
14 May

Trump Says He Will Cut Drug Prices by 59%

Reuters
·
12 May

Press Release: Cadrenal Therapeutics Reports First-Quarter 2025 Financial Results and Provides Corporate Update

Dow Jones
·
08 May

Kepler Capital Sticks to Their Buy Rating for Rational (0FRJ)

TIPRANKS
·
08 May

Kepler Capital Sticks to Their Buy Rating for Scout24 (0RB8)

TIPRANKS
·
08 May

Abbott India Says Swati Dalal Resigns As Managing Director

Reuters
·
07 May

Global Business Travel reports Q1 EPS 16c, consensus 17c

TIPRANKS
·
06 May

UK Stocks-Factors to watch on May 6

Reuters
·
06 May

Abbott Laboratories First Quarter 2025 Earnings: EPS Misses Expectations

Simply Wall St.
·
03 May

ServiceNow, Enphase, Walgreens, Abbott, Amex: Insider Moves

TIPRANKS
·
03 May

2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?

Motley Fool
·
03 May

These Companies Are Emerging as Potential Winners in Trump’s Trade War

Dow Jones
·
03 May

CORRECTED-US judge allows testimony that Abbott and Mead Johnson preterm baby formula caused deadly disease

Reuters
·
03 May

Comstock Resources to List Shares on NYSE Texas

Dow Jones
·
03 May

Investors in Abbott Laboratories (NYSE:ABT) have seen notable returns of 52% over the past five years

Simply Wall St.
·
02 May